Your browser doesn't support javascript.
loading
NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice.
Chen, Lu; Qing, Wenxiang; Yi, Zexiong; Lin, Guoxin; Peng, Qianyi; Zhou, Fan.
  • Chen L; Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Qing W; Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Yi Z; Medical College of Xiangya, Central South University, Changsha, China.
  • Lin G; Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Peng Q; Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China.
  • Zhou F; Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Nutr ; 8: 701760, 2021.
Article en En | MEDLINE | ID: mdl-34327209
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article